Raptor Pharmaceutical Corp. Company Profile (NASDAQ:RPTP)

About Raptor Pharmaceutical Corp.

Raptor Pharmaceutical Corp. logoRaptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: RPTP
  • CUSIP: 75382F10
Key Metrics:
  • Previous Close: $8.97
  • 50 Day Moving Average: $7.653
  • 200 Day Moving Average: $5.787
  • 52-Week Range: $2.94 - $9.01
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -26.37
  • P/E Growth: 0.000
  • Market Cap: $764.77M
  • Outstanding Shares: 85,306,000
  • Beta: 1.18
Profitability:
  • Net Margins: -79.29%
  • Return on Equity: -66.67%
  • Return on Assets: -17.89%
Debt:
  • Debt-to-Equity Ratio: 1.33%
  • Current Ratio: 3.57%
  • Quick Ratio: 3.30%
Additional Links:
Companies Related to Raptor Pharmaceutical Corp.:

Analyst Ratings

Consensus Ratings for Raptor Pharmaceutical Corp. (NASDAQ:RPTP) (?)
Ratings Breakdown: 6 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $8.00 (10.76% downside)

Analysts' Ratings History for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
Show:
DateFirmActionRatingPrice TargetDetails
9/16/2016Cowen and CompanyDowngradeOutperform -> Market Perform$9.00View Rating Details
9/12/2016WedbushReiterated RatingNeutral$9.00 -> $4.00View Rating Details
9/8/2016FBR & CoReiterated RatingHoldView Rating Details
8/8/2016Citigroup Inc.DowngradeBuy -> Neutral$6.00 -> $8.00View Rating Details
4/12/2016Leerink SwannReiterated RatingOutperform$11.00View Rating Details
4/11/2016Oppenheimer Holdings Inc.Reiterated RatingMarket PerformView Rating Details
3/20/2016JMP SecuritiesDowngradeHoldView Rating Details
8/22/2015Janney Montgomery ScottReiterated RatingBuyView Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q216($0.18)($0.16)$28.52 million$32.05 millionViewListenView Earnings Details
5/5/2016Q116($0.17)($0.17)$27.17 million$27.47 millionViewN/AView Earnings Details
2/25/2016Q415($0.19)($0.17)$26.08 million$24.67 millionViewListenView Earnings Details
11/5/2015Q315($0.18)($0.18)$24.25 million$25.80 millionViewListenView Earnings Details
8/6/2015Q215($0.21)($0.12)$21.40 million$23.30 millionViewN/AView Earnings Details
5/7/2015Q115($0.25)($0.24)$19.10 million$20.50 millionViewN/AView Earnings Details
2/26/2015Q414($0.14)($0.25)$20.12 million$17.30 millionViewN/AView Earnings Details
11/6/2014Q314($0.18)($0.04)$18.90 million$23.80 millionViewN/AView Earnings Details
8/7/2014Q214($0.19)($0.15)$14.58 million$16.31 millionViewN/AView Earnings Details
5/8/2014Q413($0.17)($0.20)$11.81 million$12.10 millionViewN/AView Earnings Details
3/13/2014Q313($0.18)($0.19)$10.20 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.30)($0.30)ViewN/AView Earnings Details
3/14/2013Q1 2013($0.27)($0.37)ViewN/AView Earnings Details
1/9/2013Q1 2013($0.23)($0.26)$0.25 millionViewN/AView Earnings Details
11/14/2012Q412($0.20)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
Current Year EPS Consensus Estimate: $-0.900 EPS
Next Year EPS Consensus Estimate: $-0.340 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.17)($0.15)($0.16)
Q2 20163($0.15)($0.14)($0.15)
Q3 20163($0.21)($0.15)($0.17)
Q4 20164($0.21)($0.14)($0.18)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
Insider Ownership Percentage: 5.60%
Institutional Ownership Percentage: 54.91%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/9/2015Suzanne Louise BruhnDirectorSell18,258$12.47$227,677.26View SEC Filing  
9/2/2015Raymond AndersonDirectorSell4,916$12.51$61,499.16View SEC Filing  
8/31/2015Raymond AndersonDirectorSell8,084$12.52$101,211.68View SEC Filing  
7/1/2015Llew KeltnerDirectorSell50,000$16.05$802,500.00View SEC Filing  
6/18/2015Thomas E DaleyInsiderSell35,000$15.00$525,000.00View SEC Filing  
6/10/2015Suzanne Louise BruhnDirectorSell30,000$13.45$403,500.00View SEC Filing  
5/4/2015Richard L FranklinDirectorSell10,000$9.61$96,100.00View SEC Filing  
4/2/2015Richard L FranklinDirectorSell10,000$10.37$103,700.00View SEC Filing  
3/23/2015Christopher M StarrDirectorSell20,033$11.62$232,783.46View SEC Filing  
3/2/2015Richard L FranklinDirectorSell10,000$9.18$91,800.00View SEC Filing  
2/24/2015Christopher M StarrDirectorSell30,000$9.52$285,600.00View SEC Filing  
2/2/2015Richard L FranklinDirectorSell7,109$9.20$65,402.80View SEC Filing  
1/22/2015Christopher M StarrDirectorSell30,000$9.45$283,500.00View SEC Filing  
1/15/2015Christopher M StarrDirectorSell30,000$9.73$291,900.00View SEC Filing  
1/12/2015Raymond AndersonDirectorSell10,000$10.58$105,800.00View SEC Filing  
12/22/2014Christopher M StarrCEOSell30,000$9.00$270,000.00View SEC Filing  
12/15/2014Christopher M StarrCEOSell30,000$8.15$244,500.00View SEC Filing  
11/24/2014Christopher M StarrCEOSell30,000$9.97$299,100.00View SEC Filing  
10/22/2014Christopher M StarrCEOSell30,000$10.25$307,500.00View SEC Filing  
9/23/2014Christopher M StarrCEOSell30,000$10.21$306,300.00View SEC Filing  
9/16/2014Christopher M StarrCEOSell32,896$10.60$348,697.60View SEC Filing  
9/10/2014Raymond AndersonDirectorSell10,000$10.81$108,100.00View SEC Filing  
8/25/2014Erich SagerDirectorSell10,000$11.01$110,100.00View SEC Filing  
7/7/2014Llew KeltnerDirectorSell10,000$11.21$112,100.00View SEC Filing  
5/13/2014Georgia ErbezCFOBuy16,100$7.90$127,190.00View SEC Filing  
4/7/2014Vijay SamantDirectorSell5,000$8.59$42,950.00View SEC Filing  
3/17/2014Christopher StarrCEOSell19,316$10.79$208,419.64View SEC Filing  
1/13/2014Timothy WalbertDirectorSell5,520$15.06$83,131.20View SEC Filing  
1/9/2014Thomas DaleyInsiderSell15,000$14.17$212,550.00View SEC Filing  
1/7/2014Llew KeltnerDirectorSell10,000$13.25$132,500.00View SEC Filing  
1/2/2014Richard FranklinDirectorSell10,715$13.12$140,580.80View SEC Filing  
12/9/2013Vijay SamantDirectorSell5,000$13.86$69,300.00View SEC Filing  
11/13/2013Timothy WalbertDirectorSell5,521$12.44$68,681.24View SEC Filing  
11/4/2013Richard FranklinDirectorSell10,715$14.88$159,439.20View SEC Filing  
10/15/2013Christopher M StarrCEOSell25,000$13.77$344,250.00View SEC Filing  
10/14/2013Suzanne Louise BruhnDirectorSell2,760$13.58$37,480.80View SEC Filing  
10/7/2013Vijay SamantDirectorSell5,000$14.76$73,800.00View SEC Filing  
9/16/2013Christopher StarrCEOSell25,000$14.21$355,250.00View SEC Filing  
9/16/2013Erich SagerDirectorSell17,000$14.21$241,570.00View SEC Filing  
9/13/2013Suzanne Louise BruhnDirectorSell2,760$14.07$38,833.20View SEC Filing  
9/9/2013Richard L FranklinDirectorSell10,715$14.24$152,581.60View SEC Filing  
9/9/2013Thomas E DaleyInsiderSell25,000$14.28$357,000.00View SEC Filing  
8/30/2013Georgia ErbezCFOSell7,400$13.42$99,308.00View SEC Filing  
12/28/2012Raymond AndersonDirectorSell2,000$5.50$11,000.00View SEC Filing  
11/26/2012Erich SagerDirectorSell11,279$5.00$56,395.00View SEC Filing  
9/12/2012Raymond AndersonDirectorSell2,000$5.50$11,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
DateHeadline
News IconUnder Analyst's Radar: Galectin Therapeutics Inc. (NASDAQ:GALT), Raptor Pharmaceutical Corp. (NASDAQ:RPTP) - Newburgh Press (NASDAQ:RPTP)
newburghpress.com - September 26 at 7:08 PM
News IconActive biotech company shares in the news: Agenus Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:RPTP)
voiceregistrar.com - September 23 at 6:35 PM
News Icon2 Sizzling Hot Biotechnology Stocks: Raptor Pharmaceuticals Corp ... - The Independent Republic (NASDAQ:RPTP)
theindependentrepublic.com - September 22 at 6:48 PM
News IconRaptor Pharmaceutical Corp. (NASDAQ:RPTP) Insider Trading ... - Newburgh Press (NASDAQ:RPTP)
newburghpress.com - September 22 at 6:48 PM
News IconIntraday Active Biotech Stocks News: Raptor Pharmaceuticals Corp. (NASDAQ:RPTP), Tobira Therapeutics, Inc ... - The Voice Registrar (NASDAQ:RPTP)
voiceregistrar.com - September 22 at 6:48 PM
News IconHC Stocks in Drift! Acasti Pharma Inc (ACST), Raptor Pharmaceutical Corp. (NASDAQ:RPTP) - share market updates (press release) (NASDAQ:RPTP)
sharemarketupdates.com - September 22 at 11:54 AM
sbwire.com logoThe Buyout of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Is Under Investigation Investors (NASDAQ:RPTP)
www.sbwire.com - September 21 at 6:42 PM
News IconTop Biotechnology Stock Picking: Mast Therapeutics, Inc. (MSTX), Raptor Pharmaceuticals Corp. (RPTP) - The Independent Republic (NASDAQ:RPTP)
theindependentrepublic.com - September 21 at 11:08 AM
News IconBiotech Stocks Worth a Closer Look: CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD), Raptor Pharmaceuticals Corp ... - The Voice Registrar (NASDAQ:RPTP)
voiceregistrar.com - September 21 at 11:08 AM
prnewswire.com logoSHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an ... - PR Newswire (press release) (NASDAQ:RPTP)
www.prnewswire.com - September 21 at 11:08 AM
finance.yahoo.com logoSHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Raptor Pharmaceutical Corp. -RPTP (NASDAQ:RPTP)
finance.yahoo.com - September 21 at 11:08 AM
prnewswire.com logoRAPTOR PHARMACEUTICAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Raptor ... - PR Newswire (press release) (NASDAQ:RPTP)
www.prnewswire.com - September 20 at 12:22 PM
marketrealist.com logoNews of Acquisition Caused Horizon Pharma Stock to Rise (NASDAQ:RPTP)
marketrealist.com - September 20 at 12:22 PM
finance.yahoo.com logoRAPTOR PHARMACEUTICAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Raptor … (NASDAQ:RPTP)
finance.yahoo.com - September 19 at 7:00 PM
finance.yahoo.com logoRAPTOR PHARMACEUTICAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Raptor Pharmaceutical Corp. (RPTP) Over the Proposed Sale of the Company to Horizon Pharma plc (NASDAQ:RPTP)
finance.yahoo.com - September 19 at 7:00 PM
News IconRaptor Pharmaceutical Corp. (RPTP) Cut to Market Perform at Cowen and Company (NASDAQ:RPTP)
myhealthbowl.com - September 17 at 11:32 AM
News IconRaptor Pharmaceutical Corp. (NASDAQ: RPTP) stock reaches new 52-week high - BNB Daily (blog) (NASDAQ:RPTP)
www.baseball-news-blog.com - September 16 at 6:52 PM
businesswire.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Raptor Pharmaceutical ... - Business Wire (press release) (NASDAQ:RPTP)
www.businesswire.com - September 16 at 10:41 AM
News Icon2 Biotech Stocks News And Price Trends: Raptor Pharmaceuticals Corp. (NASDAQ:RPTP), Vertex Pharmaceuticals ... - The Voice Registrar (NASDAQ:RPTP)
voiceregistrar.com - September 16 at 10:41 AM
News IconBiotech Stocks Worth a Closer Look: Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), Raptor ... - The Voice Registrar (NASDAQ:RPTP)
voiceregistrar.com - September 16 at 10:41 AM
News IconINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Raptor Pharmaceutical Corp. And Encourages ... (NASDAQ:RPTP)
ih.advfn.com - September 15 at 7:12 PM
News IconAnalyst Opinion about Healthcare Stock: Raptor Pharmaceutical Corp. (NASDAQ:RPTP) (NASDAQ:RPTP)
www.crcconnection.com - September 15 at 7:12 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding the Fairness of the Sale of Raptor Pharmaceutical Corp. to Horizon Pharma Plc for $9.00 Per Share (NASDAQ:RPTP)
finance.yahoo.com - September 15 at 7:12 PM
finance.yahoo.com logoRaptor Pharmaceuticals' (RPTP) Shares March Higher, Can It Continue? (NASDAQ:RPTP)
finance.yahoo.com - September 15 at 7:12 PM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Raptor Pharmaceutical Corp. And Encourages Shareholders To Contact The Firm For Additional Information (NASDAQ:RPTP)
finance.yahoo.com - September 15 at 7:12 PM
businesswire.com logoSHAREHOLDER ALERT: Brower Piven Commences An ... - Business Wire (press release) (NASDAQ:RPTP)
www.businesswire.com - September 14 at 7:17 PM
News IconUnusual Biotech Volume Gainers- EnteroMedics (NASDAQ:ETRM ... - Seneca Globe (NASDAQ:RPTP)
www.senecaglobe.com - September 14 at 7:17 PM
prnewswire.com logoRaptor Pharmaceutical Corp. Acquisition May Not Be in the Best Interests of RPTP Shareholders - PR Newswire (press release) (NASDAQ:RPTP)
www.prnewswire.com - September 14 at 7:17 PM
finance.yahoo.com logoRaptor Pharmaceutical Corp. Acquisition May Not Be in the Best Interests of RPTP Shareholders (NASDAQ:RPTP)
finance.yahoo.com - September 14 at 11:30 AM
News IconFrontline Matters in Notice- Raptor Pharmaceuticals (NASDAQ:RPTP), St. Jude Medical (NYSE:STJ) - Seneca Globe (NASDAQ:RPTP)
www.senecaglobe.com - September 13 at 11:59 AM
businesswire.com logoRAPTOR PHARMACEUTICAL CORP. SHAREHOLDER ALERT: Rigrodsky & Long, PA Announces Investigation Of ... - Business Wire (press release) (NASDAQ:RPTP)
www.businesswire.com - September 13 at 11:59 AM
prnewswire.com logoRAPTOR (RPTP) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in ... - PR Newswire (press release) (NASDAQ:RPTP)
www.prnewswire.com - September 13 at 11:59 AM
tmcnet.com logoRobbins Arroyo LLP: Acquisition of Raptor Pharmaceutical Corp. (RPTP) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests (NASDAQ:RPTP)
www.tmcnet.com - September 12 at 6:44 PM
reuters.com logoHorizon Pharma to buy Raptor Pharma for $800 million (NASDAQ:RPTP)
www.reuters.com - September 12 at 6:44 PM
investors.com logoHorizon Pharma snaps up Raptor Pharmaceutical for US$800mln (NASDAQ:RPTP)
www.proactiveinvestors.com - September 12 at 6:44 PM
News IconRaptor Pharmaceutical Corp. (NASDAQ:RPTP): Our Swing Trading Pick Rocked With 50% Profit In No Time (NASDAQ:RPTP)
www.marketnewscall.com - September 12 at 6:44 PM
rttnews.com logoRaptor Pharmaceutical Corp. (RPTP) Is Up Sharply After Merger Agreement (NASDAQ:RPTP)
www.rttnews.com - September 12 at 6:44 PM
News IconRaptor Pharmaceutical (RPTP) Stock Soars on Horizon Pharma Buyout (NASDAQ:RPTP)
www.investorguide.com - September 12 at 6:44 PM
investorplace.com logoDovish Fed comments sparked a rally for stocks. RPTP, P and SCTY led the way. (NASDAQ:RPTP)
investorplace.com - September 12 at 6:43 PM
News IconRobbins Arroyo LLP: Acquisition of Raptor Pharmaceutical Corp. (RPTP) by Horizon Pharma plc (HZNP) May Not Be in Shareholders... (NASDAQ:RPTP)
ih.advfn.com - September 12 at 6:43 PM
moodys.com logoHorizon Pharma PLC -- Moody's: Horizon's Raptor acquisition credit negative (NASDAQ:RPTP)
www.moodys.com - September 12 at 6:43 PM
fool.com logoWhy Raptor Pharmaceuticals, OpenText, and Freeport-McMoRan Jumped Today (NASDAQ:RPTP)
www.fool.com - September 12 at 6:16 PM
investorplace.com logoWhy Pandora Media Inc (P), Raptor Pharmaceutical Corp. (RPTP) and SolarCity Corp (SCTY) Are 3 of Today’s Best Stocks (NASDAQ:RPTP)
investorplace.com - September 12 at 5:52 PM
investorplace.com logoWhy Pandora Media Inc (P), Raptor Pharmaceutical Corp. (RPTP) and SolarCity Corp (SCTY) Are 3 of Today’s Best Stocks (NASDAQ:RPTP)
investorplace.com - September 12 at 5:14 PM
News IconRaptor Pharmaceutical, Colgate-Palmolive Company & Others: Here’s Why These Stocks Are Trending Today (NASDAQ:RPTP)
feedproxy.google.com - September 12 at 3:15 PM
bizjournals.com logoTripped up in one takeover bid, Horizon snags another Bay Area company for $800M (NASDAQ:RPTP)
feeds.bizjournals.com - September 12 at 2:30 PM
investorplace.com logoHZNP, RPTP: Horizon Pharma PLC Stock Jumps on $800 Million Raptor Pharmaceutical Corp. Buy (NASDAQ:RPTP)
investorplace.com - September 12 at 12:57 PM
feeds.benzinga.com logoShkreli Thinks Raptor Pharmaceutical's Valuation Was Too Low (NASDAQ:RPTP)
feeds.benzinga.com - September 12 at 12:42 PM
feeds.benzinga.com logoMid-Day Market Update: American Farmland Gains Following Merger News; RetailMeNot Shares Drop (NASDAQ:RPTP)
feeds.benzinga.com - September 12 at 12:42 PM
marketwatch.com logoHorizon Pharma to pay 21% premium to buy Raptor Pharmaceutical - MarketWatch (NASDAQ:RPTP)
www.marketwatch.com - September 12 at 11:51 AM

Social

Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff